Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Effect of Laryngeal Mask Airway vs Endotracheal Tube on Hypothermia in Laparoscopic Hernia Surgery (LMA-HYPOTH)

Effect of Laryngeal Mask and Endotracheal Tube Use on Perioperative Hypothermia in Laparoscopic Inguinal Hernia Surgery: A Randomized Controlled Study

This study aims to compare the effects of a laryngeal mask airway (i-gel) and an endotracheal tube on perioperative hypothermia in patients undergoing laparoscopic inguinal hernia surgery. The primary outcome is the incidence of hypothermia, defined as a core body temperature below 36°C, at the end of surgery. The study will also evaluate perioperative temperature changes and relevant postoperative outcomes between the two airway management groups.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Perioperative hypothermia is a common concern during general anesthesia and surgery. Maintaining normothermia is important for patient safety and postoperative recovery. Airway management techniques may be associated with differences in perioperative heat loss; however, their effects on body temperature in patients undergoing laparoscopic inguinal hernia surgery require further investigation.

This study is designed to compare the effects of a laryngeal mask airway (i-gel) and an endotracheal tube on perioperative hypothermia in patients undergoing laparoscopic inguinal hernia surgery under general anesthesia.

Eligible patients will be allocated to one of two groups according to the airway management technique: the i-gel group or the endotracheal tube group. Perioperative body temperature will be monitored, and the incidence of hypothermia, defined as a core body temperature below 36°C at the end of surgery, will be assessed as the primary outcome.

Additional perioperative and postoperative outcomes, including changes in body temperature and the occurrence and severity of shivering, will be evaluated and compared between the groups.

The findings may help clarify whether the choice of airway management device is associated with differences in perioperative temperature regulation in patients undergoing laparoscopic inguinal hernia surgery.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

256

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 65 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Aged 18-65 years.
  • Male or female.
  • Scheduled for elective laparoscopic inguinal hernia repair.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Body mass index (BMI) between 18 and 30 kg/m².
  • Willing to undergo general anesthesia.
  • Providing written informed consent to participate in the study.

Exclusion Criteria:

  • Requirement for emergency surgery.
  • ASA physical status IV or higher.
  • BMI below 18 kg/m² or above 30 kg/m².
  • Known upper airway anatomical abnormalities or a history of difficult airway management.
  • High risk of aspiration.
  • Known esophageal disease or gastric emptying disorder.
  • History of malignant hyperthermia.
  • Baseline core body temperature below 36°C or above 37.5°C.
  • Active infection or fever in the preoperative period.
  • Thyroid disease or endocrine/metabolic disorders that may significantly affect body temperature.
  • Use of medications that may affect perioperative body temperature.
  • Communication or cognitive impairment that may prevent adherence to the study protocol.
  • Unplanned additional surgical procedures during surgery.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: i-gel Group

Patients will undergo general anesthesia with an i-gel supraglottic airway device for airway management during laparoscopic inguinal hernia surgery. Perioperative body temperature will be monitored, and the incidence of hypothermia will be assessed.

Use of an i-gel supraglottic airway device for airway management during general anesthesia in laparoscopic inguinal hernia surgery.

Eksperimentel: Endotracheal Tube Group

Patients will undergo general anesthesia with an endotracheal tube for airway management during laparoscopic inguinal hernia surgery. Perioperative body temperature will be monitored, and the incidence of hypothermia will be assessed.

Use of an endotracheal tube for airway management during general anesthesia in laparoscopic inguinal hernia surgery.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Incidence of Perioperative Hypothermia at the End of Surgery
Tidsramme: At the end of surgery

The proportion of patients with a core body temperature below 36°C at the end of surgery will be compared between the i-gel and endotracheal tube groups.

At the end of surgery

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Core Body Temperature During Surgery
Tidsramme: From the beginning to the end of surgery

Perioperative changes in core body temperature will be compared between the i-gel and endotracheal tube groups.

From the beginning to the end of surgery
Incidence and Severity of Postoperative Shivering
Tidsramme: During the postoperative period

The incidence and severity of postoperative shivering will be assessed and compared between the two groups. Shivering severity will be graded as none, mild, moderate, or severe.

During the postoperative period

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Studiestol: Dilek Yamac, MD, Sultan 2. Abdulhamid Han Training and Research Hospital

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

15. november 2026

Primær færdiggørelse (Anslået)

15. februar 2027

Studieafslutning (Anslået)

15. februar 2027

Datoer for studieregistrering

Først indsendt

27. oktober 2026

Først indsendt, der opfyldte QC-kriterier

27. oktober 2026

Først opslået (Faktiske)

3. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

3. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

27. oktober 2026

Sidst verificeret

1. oktober 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • SBU-ANESTEZİ-DMY-07

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Individual participant data will not be shared with other researchers.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .